-
公开(公告)号:EP3178925B1
公开(公告)日:2021-10-06
申请号:EP15830033.5
申请日:2015-08-07
发明人: AZUMA Noriyuki , TANAKA Taku , YOKOI Tadashi
-
公开(公告)号:EP3861982A3
公开(公告)日:2021-09-01
申请号:EP20208058.6
申请日:2014-12-05
申请人: ALLERGAN, INC.
发明人: Maynor, Benjamin , Garcia, Andres , Das, Sanjib Kumar , Navratil, Tomas , Yerxa, Benjamin Robinson , Tully, Janet
IPC分类号: A61K9/00 , A61K47/34 , A61K31/5575 , A61P27/06 , A61P27/02
摘要: The present invention relates to a pharmaceutical composition for treating an ocular condition, comprising a biodegradable polymer matrix and at least one therapeutic agent homogenously dispersed within the polymer matrix. The composition can be in the form of an ocular implant.
-
53.
公开(公告)号:EP3868218A1
公开(公告)日:2021-08-25
申请号:EP19873759.5
申请日:2019-09-03
申请人: Genencell Inc.
发明人: JEONG, Yong Joon , KANG, Se Chan , PARK, Dae Won , SO, Ri Na
IPC分类号: A23L33/105 , A61K36/23 , A61K9/00 , A61P27/02 , A61P27/06
摘要: The present invention relates to a composition for preventing and alleviating or treating glaucoma and macular degeneration, containing a Centella asiatica extract. Particularly, the composition increases the glucose metabolism efficiency of cells so as to increase the survival rate of retinal neurons and pigment epithelial cells and protects cells from oxidative damage caused by A2E, thereby being effectively usable as a composition for eye health and for preventing and alleviating or treating glaucoma and macular degeneration.
-
公开(公告)号:EP3863630A1
公开(公告)日:2021-08-18
申请号:EP19871827.2
申请日:2019-10-08
发明人: HORN, Gerald
IPC分类号: A61K31/439 , A61J1/00 , A61K9/08 , A61P27/06
-
公开(公告)号:EP3352856B1
公开(公告)日:2021-08-18
申请号:EP16849594.3
申请日:2016-09-22
发明人: PETERS, Kevin Gene
IPC分类号: A61K31/426 , A61K31/427 , A61K31/428 , A61K31/433 , A61K31/496 , A61K31/497 , A61K31/513 , A61P27/02 , A61P27/06 , C07D417/04
-
公开(公告)号:EP3449925B1
公开(公告)日:2021-08-04
申请号:EP18173639.8
申请日:2014-03-13
发明人: Haydon, Philip G. , Lee, Jinbo
IPC分类号: A61K31/7072 , A61K31/7064 , A61K31/7068 , A61P25/04 , A61P25/28 , A61P27/06 , A61P29/00 , A61P37/00 , C07H19/067 , C07D405/04 , C07D405/14
-
公开(公告)号:EP3280435B1
公开(公告)日:2021-06-02
申请号:EP16777003.1
申请日:2016-04-06
-
-
公开(公告)号:EP3811936A1
公开(公告)日:2021-04-28
申请号:EP20189704.8
申请日:2020-08-05
申请人: Scorolli, Lucia
发明人: Scorolli, Lucia
IPC分类号: A61K31/137 , A61K31/138 , A61K31/573 , A61K31/711 , A61K31/714 , A61K35/00 , A61K45/06 , A61K9/00 , A61P27/00 , A61P27/02 , A61P27/06
摘要: We propose a para-bulbar preparation with a cytotrophic-retinal effect, consisting of a mixture of active ingredients including:
a) betamethasone;
b) isoxysuprine hydrochloride or ritrodine hydrochloride;
c) phospholipids from the cerebral cortex added to cyanocobalamin;
d) polydeoxyribonucleotide or Coenzyme Compositum®.
The various components of the mixture are provided according to the following quantities:
a) betamethasone: 4 mg / 2 ml (s.i.) = 5 U = 0.05 ml;
b) isoxysuprine hydrochloride: 2 ml (s.i.), or ritrodine hydrochloride 50 mg / 5 ml = 20 U = 0.20 ml;
c) Cerebral cortex phospholipids added to cyanocobalamin: 12 mg and 1 mg / 2 ml respectively, (s.i.) = 10 U = 0.10 ml;
d) polydeoxyribonucleotide: 5.625 mg / 3 ml (s.i.) = 15 U = 0.15 ml; for a total of 0.5 ml, corresponding to 50 U.
We also propose a package containing the aforementioned active ingredients, designed to contain a single dose, consisting of a sterile syringe or vial with a piston locking device, made of plastic..-
公开(公告)号:EP3606546B1
公开(公告)日:2021-04-28
申请号:EP18715911.6
申请日:2018-03-28
发明人: WIDDOWSON, Peter , MARTIN, Keith
-
-
-
-
-
-
-
-
-